Man Group’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.8M | Buy |
671,513
+410,653
| +157% | +$20.1M | 0.06% | 312 |
|
|
2025
Q1 | $13.3M | Buy |
+260,860
| New | +$13.3M | 0.03% | 516 |
|
|
2024
Q1 | – | Sell |
-9,700
| Closed | -$267K | – | 2105 |
|
|
2023
Q4 | $267K | Buy |
+9,700
| New | +$267K | ﹤0.01% | 1724 |
|
|
2023
Q3 | – | Sell |
-11,226
| Closed | -$457K | – | 564 |
|
|
2023
Q2 | $457K | Buy |
+11,226
| New | +$457K | ﹤0.01% | 1580 |
|
|
2023
Q1 | – | Sell |
-189,561
| Closed | -$7.24M | – | 2159 |
|
|
2022
Q4 | $7.24M | Buy |
+189,561
| New | +$7.24M | 0.03% | 697 |
|
|
2022
Q3 | – | Hold |
0
| – | -$1.24M | – | 2127 |
|
|
2022
Q2 | – | Sell |
-24,306
| Closed | -$907K | – | 1250 |
|
|
2022
Q1 | $907K | Buy |
+24,306
| New | +$907K | ﹤0.01% | 1391 |
|
|
2021
Q2 | – | Sell |
-38,669
| Closed | -$1.83M | – | 1983 |
|
|
2021
Q1 | $1.83M | Sell |
38,669
-36,263
| -48% | -$1.72M | 0.01% | 1136 |
|
|
2020
Q4 | $4.57M | Sell |
74,932
-19,949
| -21% | -$1.22M | 0.02% | 855 |
|
|
2020
Q3 | $4.44M | Sell |
94,881
-21,903
| -19% | -$1.02M | 0.02% | 872 |
|
|
2020
Q2 | $5.93M | Buy |
116,784
+62,206
| +114% | +$3.16M | 0.03% | 587 |
|
|
2020
Q1 | $2.43M | Sell |
54,578
-8,179
| -13% | -$365K | 0.02% | 805 |
|
|
2019
Q4 | $3.01M | Sell |
62,757
-1,000
| -2% | -$48K | 0.01% | 1185 |
|
|
2019
Q3 | $2.16M | Sell |
63,757
-81,844
| -56% | -$2.77M | 0.01% | 1215 |
|
|
2019
Q2 | $6.55M | Sell |
145,601
-29,419
| -17% | -$1.32M | 0.02% | 835 |
|
|
2019
Q1 | $6.59M | Buy |
175,020
+19,963
| +13% | +$751K | 0.03% | 762 |
|
|
2018
Q4 | $5.32M | Sell |
155,057
-12,247
| -7% | -$420K | 0.02% | 733 |
|
|
2018
Q3 | $7.86M | Buy |
167,304
+19,782
| +13% | +$930K | 0.03% | 732 |
|
|
2018
Q2 | $4.98M | Buy |
+147,522
| New | +$4.98M | 0.02% | 934 |
|